Tags : Germany

Biotech COVID-19

Pfizer and BioNTech Elicits Strong T-cell Response in P-I/II Study

Shots: The companies reported that most advanced of four COVID-19 vaccine candidates from their BNT162 mRNA-based vaccine program demonstrated the ability to elicit high SARS-CoV-2 neutralizing titers following the second dose in an ongoing P-I/II study in Germany The results divulge that BNT162b1 candidate induced strong CD4+ and CD8+ T-cell responses. BNT162b1 elicits RBD-specific, interferon-g+, […]Read More

COVID-19 Pharma

Pfizer and BioNTech to Commence Clinical Study for COVID-19 in

Shots::sto sosohththShots: The Paul-Ehrlich-Institut has approved the P-I/II clinical study evaluating BioNTech’s BNT162 vaccine program to prevent COVID-19 infection. The clinical study is the first COVID-19-related trial to be initiated in Germany The P-I/II study’s dose-escalation portion will include ~200 healthy subjects aged 18-55yrs. and will target a dose-ranging 1-100 µg to determine the optimal […]Read More


Wuxi Biologic to Acquire Bayer’s Production Facility in Germany

Shots: Wuxi Biologic to take over operations of Bayer’s manufacturing plants in Leverkusen, Germany and purchase its associated equipment in combination with a long-term lease contract for the building As per the manufacturing agreement to be negotiated, Wuxi operated plant shall serve as a backup site for manufacturing Kovaltry, an antihemophilic factor (recombinant) while Bayer’s […]Read More


Medtronic’s MiniMed 670G Insulin Pump System Receives Reimbursement for Patients

Shots: Medtronic reports that it has secured for its reimbursement for the MiniMed 670G insulin pump system with the German Federal Association of the Statutory Health Insurances (GKV-SV). The reimbursement agreement will be effective from Aug 29, 2019 The granted reimbursement will increase the accessibility of Medtronic’s MiniMed 670G Insulin pump system to more patients […]Read More


Fraunhofer MEVIS’ Experts Develops Intelligent Catheter Navigation System in Germany

Shots: Fraunhofer Institute for Digital Medicine MEVIS has developed IntelliCath, an intelligent catheter navigation to precisely navigate the catheter into the blood vessels in applying stents or removing blood clots The catheter is equipped with optical fiber containing tiny mirrors reflecting a portion of the light that changes color when the fibre bends which provide […]Read More